recommended in this report, or are you looking for details on the newer Technical Report No. 86
: Guidance on maintaining barrier quality from product development through its entire life cycle.
Testing how the package handles shipping and handling stress. 2. Package Integrity and Leak Rate Specifications
The Parenteral Drug Association (PDA) is a non-profit organization founded in 1946. It is a leading global provider of science, technology, and regulatory information for the pharmaceutical and biopharmaceutical industries. PDA's mission is to advance pharmaceutical and biopharmaceutical manufacturing science and regulation, ultimately to better serve patients. pda technical report 27 pdf
The direct source. PDA sells TR 27 as a downloadable PDF (price typically $250–350 for members, higher for non-members). Members receive a discount, and membership often pays for itself if your company needs multiple reports.
: Technical details on specific testing procedures. Accessing the Full Document
Ensuring manufacturing processes (e.g., sealing, crimping) do not compromise the package. recommended in this report, or are you looking
is one of the most influential guidance documents in the pharmaceutical and biotechnology industries concerning container closure integrity (CCI). Published by the PDA, a leading global association providing science and technology information for the pharmaceutical and biopharmaceutical communities, this report serves as a foundational reference for evaluating the sterility and stability of packaging systems.
ISO 11607 applies to terminally sterilized medical device packaging. TR 27 covers aseptically filled and terminally sterilized drug products, with greater emphasis on microbial ingress correlation.
, titled "Pharmaceutical Package Integrity," was originally published in 1998 by the Parenteral Drug Association (PDA) . It provides comprehensive guidance on evaluating the barrier qualities of pharmaceutical packaging, specifically focusing on sterile products. Report Overview given the pace of technological advancement
: Methods for establishing a correlation between physical leak tests and microbial ingress.
For those needing to access the "," the official sources are the PDA Bookstore for purchase and PDA membership for benefits and potential access. However, given the pace of technological advancement, the industry is on the cusp of receiving updated guidance from PDA. The retirement of TR 27 in favor of a new, more modern technical report is a necessary evolution that will help manufacturers meet today's higher expectations for pharmaceutical product quality and patient safety. For now, TR 27 remains a foundational and critical reference, but professionals should continue to monitor PDA channels for the release of its eventual successor.
Factors like cost, time, and whether the test is destructive or non-destructive. 4. Microbial Package Integrity Methods
This article explores the core concepts, methodologies, and regulatory context established by PDA Technical Report No. 27, serving as a comprehensive reference for quality control and packaging professionals. 1. Overview and Scope of PDA TR 27